These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11588711)

  • 1. [Medical treatment of pervasive developmental disorders].
    Fuentes J; Gallano I
    Rev Neurol; 2001 Aug 1-15; 33(3):208-10. PubMed ID: 11588711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pervasive developmental disorders. Clinical and genetics aspects].
    Ruggieri V; Arberas C
    Medicina (B Aires); 2007; 67(6 Pt 1):569-85. PubMed ID: 18422083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment options for autism spectrum disorders in children and adolescents.
    Leskovec TJ; Rowles BM; Findling RL
    Harv Rev Psychiatry; 2008; 16(2):97-112. PubMed ID: 18415882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
    Findling RL
    J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use.
    Martin A; Scahill L; Klin A; Volkmar FR
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):923-31. PubMed ID: 10405512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autism spectrum disorders in early childhood: an overview for practicing physicians.
    Carr JE; LeBlanc LA
    Prim Care; 2007 Jun; 34(2):343-59; abstract viii. PubMed ID: 17666231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials.
    Sturmey P
    Res Dev Disabil; 2005; 26(1):87-97. PubMed ID: 15590241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretin treatment for autism.
    Rimland B
    N Engl J Med; 2000 Apr; 342(16):1216-7; author reply 1218. PubMed ID: 10777377
    [No Abstract]   [Full Text] [Related]  

  • 12. Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability.
    Chez MG; Burton Q; Dowling T; Chang M; Khanna P; Kramer C
    J Child Neurol; 2007 May; 22(5):574-9. PubMed ID: 17690064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
    de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
    Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention deficit hyperactivity disorder symptoms in pervasive developmental disorders: association with autistic behavior domains and coexisting psychopathology.
    Holtmann M; Bolte S; Poustka F
    Psychopathology; 2007; 40(3):172-7. PubMed ID: 17318010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
    Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
    Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling clinical outcome of children with autistic spectrum disorders.
    Coplan J; Jawad AF
    Pediatrics; 2005 Jul; 116(1):117-22. PubMed ID: 15995041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of pervasive developmental disorders in preschool children in the UAE.
    Eapen V; Mabrouk AA; Zoubeidi T; Yunis F
    J Trop Pediatr; 2007 Jun; 53(3):202-5. PubMed ID: 17244665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting symptom domains: a strategy for pharmacotherapy in childhood pervasive developmental disorders.
    Namerow LB; Mangini LM
    Conn Med; 2005 Oct; 69(9):525-33. PubMed ID: 16270789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autistic traits in the general population: a twin study.
    Constantino JN; Todd RD
    Arch Gen Psychiatry; 2003 May; 60(5):524-30. PubMed ID: 12742874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.